šŸ“£ Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. (2015)

First Author: OuƩdraogo AL
Attributed to:  MRC Centre for Outbreak Analysis and Modelling Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciu797

PubMed Identifier: 25414262

Publication URI: http://europepmc.org/abstract/MED/25414262

Type: Journal Article/Review

Volume: 60

Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Issue: 3

ISSN: 1058-4838